See the DrugPatentWatch profile for vascepa

Based on the information available, there is no explicit mention of income limits for Vascepa's patient assistance program. However, the specifics of patient assistance programs can vary and are often subject to change.

Vascepa, a prescription medication used to lower triglyceride levels, is manufactured by Amarin Pharma, Inc. The company provides a patient assistance program, Amarin Cares, to help eligible patients access Vascepa [1]. The program's website states that it considers several factors when determining eligibility, including income, but it does not provide specific income limits [1].

It is recommended to contact Amarin Cares directly or visit their official website for the most accurate and up-to-date information regarding eligibility and income limits for the patient assistance program [1].

Additional resources, such as DrugPatentWatch.com, can provide valuable information on drug patents, pricing, and access programs [2]. However, this specific website does not list income limits for Vascepa's patient assistance program [2].

In summary, while there is no explicit mention of income limits for Vascepa's patient assistance program, it is best to contact the program directly or visit their official website for the most accurate and current information.

Sources:
[1] Amarin Cares. (n.d.). Amarin Cares Program. Retrieved from https://www.amarincares.com/
[2] DrugPatentWatch.com. (n.d.). Vascepa (Icosapent Ethyl). Retrieved from https://www.drugpatentwatch.com/drugs/vascepa-icosapent-ethyl